<SEC-DOCUMENT>0001654954-20-008352.txt : 20200804
<SEC-HEADER>0001654954-20-008352.hdr.sgml : 20200804
<ACCEPTANCE-DATETIME>20200804074816
ACCESSION NUMBER:		0001654954-20-008352
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200804
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200804
DATE AS OF CHANGE:		20200804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			cbdMD, Inc.
		CENTRAL INDEX KEY:			0001644903
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				473414576
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38299
		FILM NUMBER:		201070983

	BUSINESS ADDRESS:	
		STREET 1:		8845 RED OAK BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28217
		BUSINESS PHONE:		704-445-3060

	MAIL ADDRESS:	
		STREET 1:		8845 RED OAK BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Level Brands, Inc.
		DATE OF NAME CHANGE:	20170202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEVEL BEAUTY GROUP, INC.
		DATE OF NAME CHANGE:	20150611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ycbd_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>ycbd_8k</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
UNITED STATES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Washington, DC 20549</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
FORM 8-K</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CURRENT REPORT</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Date of Report (Date of earliest event reported)</font>
<font style="text-decoration: underline">August 4,
2020</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_8k000.jpg"></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
cbdMD, INC.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Exact name of registrant as specified in its charter)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 33%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
North Carolina</font></div>
</td>
<td style="vertical-align: top; width: 34%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
001-38299</font></div>
</td>
<td style="vertical-align: top; width: 34%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
47-3414576</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 33%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(State or other jurisdiction of incorporation or
organization)</font></div>
</td>
<td style="vertical-align: top; width: 34%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Commission File Number)</font></div>
</td>
<td style="vertical-align: top; width: 34%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(I.R.S. Employer Identification No.)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
8845 Red Oak Blvd, Charlotte, NC 28217</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Address of principal executive offices)(Zip Code)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Registrant's
telephone number, including area code<font style="font-variant: small-caps">:</font> <font style="font-weight: bold">(704) 445-3060</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
_______________________________________</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Former name or former address, if changed since last
report)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#x2610;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#x2610;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#x2610;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">&#x2610;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Securities
registered pursuant to Section 12(b) of the Act:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 37%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Title of each class</font></div>
</td>
<td style="vertical-align: top; width: 25%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Trading Symbol(s)</font></div>
</td>
<td style="vertical-align: top; width: 38%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Name of each exchange on which registered</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 37%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">common</font></div>
</td>
<td style="vertical-align: top; width: 25%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">YCBD</font></div>
</td>
<td style="vertical-align: top; width: 38%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">NYSE
American</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 37%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8%
Series A Cumulative Convertible Preferred Stock</font></div>
</td>
<td style="vertical-align: top; width: 25%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">YCBD PR
A</font></div>
</td>
<td style="vertical-align: top; width: 38%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">NYSE
American</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Indicate by check mark whether the registrant is an emerging growth
company as defined in in Rule 405 of the Securities Act of 1933
(</font>&#xA7;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this
chapter)<font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 49%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Emerging
growth company &#x2611;</font></div>
</td>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act.&#xA0;&#x2610;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; break-after: page; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: rgb(255, 255, 255);">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;"></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="display: table-cell; width: 84px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Item</font>
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">2.02&#xA0;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Results
of Operations and Financial Condition.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">On
August 4, 2020 cbdMD, Inc. issued a press release announcing the
unaudited net sales of its Paw CBD, Inc. subsidiary for the third
quarter of fiscal 2020. A copy of this press release is furnished
as Exhibit 99.1 to this report.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant to General
Instruction B.2 of Form 8-K, the information in this Item 2.02 of
Form 8-K, including Exhibit 99.1, is being furnished and shall not
be deemed &#x201C;filed&#x201D; for the purposes of Section 18 of the
Securities Exchange Act of 1934 or otherwise be subject to the
liabilities of that section, nor is it incorporated by reference
into any filing of cbdMD, Inc. under the Securities Act of 1933 or
the Securities Exchange Act of 1934, whether made before or after
the date hereof, regardless of any general incorporation language
in such filing.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="display: table-cell; width: 84px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Item</font>
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">9.01&#xA0;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Financial
Statements and Exhibits.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">(d)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="text-decoration: underline">Exhibits</font>.</font></div>
</div>
</div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 5%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 56%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="5" style="vertical-align: bottom; width: 26%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Incorporated&#xA0;by&#xA0;Reference</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="2" style="vertical-align: bottom; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Filed&#xA0;or</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Furnished</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Herewith</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 5%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
No.</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 56%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Exhibit&#xA0;Description</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Form</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Date Filed</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Number</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 56%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="ycbd_ex991.htm"><font style="font-family: Times New Roman; font-size: 13px">99.1</font></a></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 56%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Press
release dated August 4, 2020</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Furnished</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SIGNATURES</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 53%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">cbdMD,
Inc.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 53%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 41%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 53%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Date:
August 4, 2020</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:</font></div>
</td>
<td style="vertical-align: top; width: 41%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
Mark S. Elliott</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 53%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 41%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mark S.
Elliott, Chief Financial Officer and Chief Operating
Officer</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ycbd_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>ycbd_ex991</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: right; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-family: Times New Roman; font-size: 13px">Exhibit
99.1</font><br></font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
cbdMD&#x2019;s Pet Brand, Paw CBD, Sees Sales Increase
64%</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
&#xA0;from March 2020 Quarter to June 2020 Quarter</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_ex991000.jpg"></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">CHARLOTTE,
N.C. &#x2014; August 4, 2020 &#x2014; (BUSINESS WIRE) -- cbdMD, Inc.
(NYSE American: YCBD, YCBD PR A) (the &#x201C;Company&#x201D;), one
of the leading and most highly trusted and recognized cannabidiol
(CBD) brands, announced today that its pet CBD brand, Paw CBD, has
seen an approximate 64% increase in net sales from its March 2020
quarter of approximately $750,000 to approximately $1,229,000 for
its June 2020 quarter.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x201C;Paw
CBD was launched less than one year ago, and now it is one of
America&#x2019;s leading CBD pet brands,&#x201D; said Ken Cohn, CMO
of cbdMD, Inc. <font style="font-weight: bold">&#x201C;</font>Sales
metrics are all moving in the right direction, with Paw CBD now
trending at over a $7mm annualized run rate, and cbdMD&#x2019;s
overall direct-to-consumer (DTC) sales making up over 70% of the
brand&#x2019;s revenue. We are seeing the DTC power of cbdMD.com
translating into significant growth for
PawCBD.com.&#x201D;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Cohn
continued: &#x201C;In the meantime, we continue to focus on
cross-selling, customer retention and education and will be rolling
out Paw CBD subscription and reward programs shortly. As we mimic
the expansion of our original cbdMD products, we are confident that
Paw CBD will be a leader in the CBD pet market.&#x201D;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
preliminary financial information contained in this press release
has been prepared internally by management and has not been
reviewed or audited by our independent registered public accounting
firm. There can be no assurance that actual results for the periods
presented herein will not differ from the preliminary financial
information presented herein and such changes could be material.
This preliminary financial data should not be viewed as a
substitute for full financial statements prepared in accordance
with GAAP and is not necessarily indicative of the results to be
achieved for any future period.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
About Paw CBD</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Paw CBD
is the pet division of cbdMD, whose veterinarian-formulated
products include tinctures, chews, and topicals in varying
strengths and formulas. Committed to bringing high-quality options
for the animals in your life, Paw CBD is proud to offer premium,
non-THC<font style="font-size: 70%; vertical-align: top"><a href="#ref.BAACD1">1</a></font> CBD products, specially created to
maintain your pets&#x2019; ongoing wellbeing and happiness. To learn
more about the comprehensive line of Paw CBD pet products, please
visit <font style="text-decoration: underline; color: #1155CC">pawcbd.com</font> or
follow Paw CBD on <font style="text-decoration: underline; color: #1155CC; background-color: #FEFEFE">
Instagram</font> <font style="color: #444444; background-color: #FEFEFE">and</font> <font style="text-decoration: underline; color: #1155CC; background-color: #FEFEFE">
Facebook</font><font style="color: #444444; background-color: #FEFEFE">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
About cbdMD, Inc.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">cbdMD,
Inc. is one of the leading and most highly trusted and recognized
cannabidiol (CBD) brands whose current products include CBD
tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs
and CBD pet products. cbdMD is also a proud partner of Bellator MMA
and Life Time, Inc., and has one of the largest rosters of
professional sports athletes who are part of &#x201C;Team
cbdMD.&#x201D; To learn more about cbdMD and our comprehensive line
of over 100 SKUs of U.S. produced, Non THC<font style="font-size: 70%; vertical-align: top">1</font> CBD products, please
visit <font style="text-decoration: underline; color: #1155CC">www.cbdMD.com</font>,
follow cbdMD on <font style="text-decoration: underline; color: #1155CC">Instagram</font> and
<font style="text-decoration: underline; color: #1155CC">Facebook</font>, or
visit one of the 6,000 retail outlets that carry cbdMD
products.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Forward-Looking Statements</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
This presentation contains certain forward-looking</font>
<font style="color: #000000">statements that are based upon current
expectations and involve certain risks and uncertainties within the
meaning of the U.S. Private Securities Litigation Reform Act of
1995. Such forward-looking statements can be identified by the use
of words such as &#x2033;should,&#x2033; &#x2033;may,&#x2033;
&#x2033;intends,&#x2033; &#x2033;anticipates,&#x2033;
&#x2033;believes,&#x2033; &#x2033;estimates,&#x2033;
&#x2033;projects,&#x2033; &#x2033;forecasts,&#x2033;
&#x2033;expects,&#x2033; &#x2033;plans,&#x2033; and
&#x2033;proposes.&#x2033; These forward-looking statements are not
guarantees of future performance and are subject to risks,
uncertainties, and other factors, some of which are beyond cbdMD,
Inc.&#x2019;s control and difficult to predict and could cause
actual results to differ materially from those expressed or
forecasted in the forward-looking statements including, without
limitation, the continued consumer acceptance of Paw CBD, our
ability to maintain or increase net sales from this product line,
and</font> statements made with respect to our actual financial
results for the third quarter of fiscal 2020 and the nine months
ended June 30, 2020 to be contained in our Quarterly Report on Form
10-Q to be filed with the Securities and Exchange Commission
(&#x201C;SEC&#x201D;)<font style="color: #000000">. You are urged to
carefully review and consider any cautionary statements and other
disclosures, including the statements made under the heading "Risk
Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal
year ended September 30, 2019 and Part II, Item 1A. Risk Factors
appearing in its Quarterly Report on Form 10-Q for the period ended
March 31, 2020, both as filed with the SEC, and our other filings
with the SEC. All forward-looking statements involve significant
risks and uncertainties that could cause actual results to differ
materially from those in the forward-looking statements, many of
which are generally outside the control of cbdMD, Inc. and are
difficult to predict. cbdMD, Inc. does not undertake any duty to
update any forward-looking statements except as may be required by
law. The information which appears on our websites and our social
media platforms, including, but not limited to, Instagram and
Facebook, is not part of this presentation.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Contact:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">PR:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">cbdMD,
Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Lauren
Greene</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Communication
Specialist</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #1155CC; font-family: Times New Roman; font-size: 13px">
lauren.greene@cbdmd.com</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">843-743-9999</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Investors:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">cbdMD,
Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">John
Weston</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Director
of Investor Relations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #1155CC; font-family: Times New Roman; font-size: 13px">
john.weston@cbdmd.com</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">704-249-9515</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><a name="ref.BAACD1"><font style="font-size: 70%; vertical-align: top">1</font><font style="font-family: Times New Roman">&#xA0;</font>Non-THC is defined as
below the level of detection using validated scientific analytical
tools.</a></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ycbd_8k000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_8k000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  P *,# 2(  A$! Q$!_\0
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M,#/'O52Q5-NFTK69-++J\%53=^9:,YSX5?\ ( O/^OH_^@BNOU'2K+55@%[
MLH@E$L>>S#^GM57P_P"'K3PY9R6UI)*Z22>83*03G '8#TK7KDKU%*JYQ/3P
MM%PH1IS6R"O#+S_DHLG_ &$__:E>YUR<GP_TN76VU5I[KSVG^T;0XV[LY].E
M:82M&DY<W5&&88:I74%#H[G(?%3_ )&&T_Z]?_9C6YH7C[0M/T&QLYY)Q-#"
MJ.%A)&0*W?$'@W3_ !'>QW5W-<(\<?E@1, ,9SW!]:R/^%6:+_S]7W_?:_\
MQ-;JMAYT8TZE].QS2PV+IXB=6BE[W<CU'XI:;%"PT^VGN)L<&1=BCZ]ZXK3=
M,U7QQK[S2LQ#L#<7&/EC7T'OCH*]"M?AIX?MY \B7%QC^&67C\ABNJM;2WLK
M=;>UACAA7HB+@"I^LT:*?L%J^K*^IXC$R3Q4ERKH@M;:*RM(;6!=L42!$7T
-HJ:BO/;N>NDDK(__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ycbd_ex991000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_ex991000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M  (1 Q$ /P#W^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO].*3.AJZ[(;QEV-N\W!PV!C[I7CK^AYY%>C?\*OT3_GZU#_ +^)_P#$4?\
M"K]$SC[5J'_?Q/\ XBCZQ3[L/K%/NS@+FX\/M=Q-;:=,MO\ .)$9CGD?*0=Y
MY'7_ ![0[=$\EL#4/,*<9*85L#'UYS^%>B_\*PT7_GZU#_OXG_Q%._X5AHO_
M #]:A_W\3_XBCV]/NP^L4^[/*57I7M?PPM)+7PIND:,^?.TJ['#8&U1SCH>.
MG45ECX9:*.EU?\?]-$_^(KK_  UH=MH&F-:6CS/&TAD)E()R0!V ]*SKUHSC
M9&5>M&<;(V:***Y#D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&P,@X/4 Y!X]>KKP[]G<XL/$)'9H3_Z,KB[_ ,<>*+^Y:2;7;Y<\;89C$O\
MWRF!^E 'U+2%@.I _&OD*>]NKD[KBYFF;UD<L?UJMZT ?8#WEK']^YA7_>D
MJ,:II[' O[4GT$R_XU\AT=Z /L-+B&3[DT;?[K U)FOCCC-*I(;@_E0!]8^)
M4\WPOJJ=<VDO_H)JKX/U(:MX8L[ACF14\N3/7<O!/X]?QKYIL]6U&V=8X=0N
MHXV(5T29@&!Z@@'D5[)\+-3\N:ZTUV^60^;'S_$.H_$8_*M8QYJ;?8VC&]-^
M1Z3*E4I 036DXR*JR1YS6)D9-Q86MTQ>:WC=R I8CG S@?J?S-0MI&GM(7-I
M%N)SP._/^)_.M&0;<5$#S5)L+LJ-I5A)'M:TA(^7^'GC..?;)_,TU=&TY 0M
MI$ 1@X';.<?G7.[]8>ZF^UG44_>84V\9* <Y/ Z=* -2S'_I.J@%<LQ@?Y3Z
M=*XOKO\ =9T*@_YCIXM*L(2Q2UC!9@Q.,\@@@_F :$T73L$+:1@,<G&17.1-
M?E9#)>:A$V0$W1.PZ#)/R^N1_GF0:E=PQ@C4YU8+DJT /..G('^32>/25VG]
MZ_S&L/*^C_,[&RLH+*%DMX]B$[L D\X _H*OP?ZE:R])GN)]'BFNAB9@<Y&,
MC/!Q]*FAN9267<, D#BNN$^>*DNIS233:9I454\YSWH\U_[U4(MT55\V3^]^
ME!E?^]0!:HJIYK_WJ9)<RJA(;GZ4 7JY+Q_X[M/ >C17D\#7-Q/)Y<$ ?9N/
M4DM@X 'MZ5LV6H337?DN%(P>0.:\C_:1(_L?01GDW$N!_P !6@#MOAW\2K;Q
MZEU']B-G=VX#-%YGF!E/&0<#OVQW')[=G=WD%C#YMP^Q<X'!.3^%?/\ ^SO_
M ,C#JW_7H/\ T):]F\9%QHN8_P#6!CLQZ[3B@#0TW5DU)YO+B9$CVX+$9.<]
MA]/6M#-<CX%S_9C%M^?*BSYGWNAZ^];FN?;#HUQ_9X9KC VA#AB,C< >QQG%
M.VMAVUL:6:,US_AJ6[2"6*^DD"M+BU%QN61U"C<<.2W7)Y)/X8K<CECD=PCJ
MQ0[7"G.TX!P?0X(/XT-6=@:L[$M%%%(04444 %%%(S*BEF("@9)- "T5634+
M:3[DF[\#4GVA/?\ *@"6BHOM"^AH\]?0T 2T5%YZ^AH^T)Z&@"6J>IZK8:-9
MM=ZE>0VL .-\K8R<9P/4\'@<U/\ :8QU)_*O-/C3=0S^$+.-'RW]H1Y&#TV/
M3BKNPTKNQ;?XR^'C=216MO>W$2?\MEC"AOH&(/Y@4\?&#0<?-9:D/HD?_P 7
M7AVGV[/J%Q;VP\UC($C"+][DXP*WM.M;O3[^"[N=/N_(0L2RQ'(P#EAD8R.O
MX5TJE#J;.$4KGJ@^,'A\G!M-3'UBC_\ BZW?#_CC1_$M\UG8&<3K$92LL>WY
M00#SGU85XOK%K>ZBD=Q!I][(L$3>=,\3<X8YZY)"GCDDCOC%=)\*[*ZL/&\T
M5W;R02-ISN$D7:V#(F,@\CI2G2@D[$J*<.;9GHGC;QG8>!]".I7RM*SOY4$*
M'!D<@D#/8<<GM61\/?B=8^/#/ +1K*^A7S##YGF*4R!D-A>02,@CN,9YQRG[
M1O\ R*FD_P#7Z?\ T UR7[/7_([7O_8/?_T.*N8R/I.BBB@ HHHH **** "B
MBB@"L-0MF<HLF6!P< U)]H3W_*N5@O-M[/&EM<R.DA! B*\Y[%L _4&M'[?=
MCIHM\WTD@_K)0!L^>OO^5+YZ>_Y5CB_NS_S!;X?]M(/_ ([3OMMW_P! :]_[
M^0?_ !R@#5\]/0TGVF,=<_E60;^['_,$OS_VTM__ ([33?71!W:/>H/4O"?Y
M2&@"YJ)_M/3;VSL[DPW$ENZ)("5,;,,!LCT//%9!\*MYOFGQ!J8?<'_UX(!&
M.,,#\O'3W/)S3[:[A<:CYJ7,:I;,TF8V4A>^#T)_&L@C2HV$+1W#,J@9*0G^
M(+C=R,\USUJTJ;22O\S6G34MV7KGP;I4URD\VIW&Y&C92QB+910H^<IN![Y!
MR"25(S4D>BVGAWPM<6]C/))$TGF^83&AS@#@JJK_  CG')R3G-4772=T*_Z6
M1(B,N5B& ^6 QCIU]LXK4C2V_P"$4!LRS1R?/A@'*L><8&!QZ4J-:4Y6:_$)
MTXQ5TSG=6\3W'A#P3JFM6]ND]Q!(BA)@%!+.J\[.#C-?/?C;QSJ'CK5K>_U&
MWMX6MX?)2.#<%QDDDY)YY_05[CX\TN]U'X=ZI8:58R7$\LD!$,%N0>'!) _X
M"*^:G@GCE='C"LIVL">A'XUTMF239V7@GX@:EX&-TNG6UM.MTBAQ<!CC&2,8
M(_O&F);W$L44IAD7S4#J-AY![CU'!YKG[:TDN;V*")=[2$*H!&23V'O7N?A:
MQTO2?"FF2:_']DD8^2WG%EPQ9L XZ9 ZGBIES6]PN*C?WSS/^R[T]+:;G_ID
MW^%*-'OF_P"7:7_ODC^E?1L7AK1BH(L__(K_ .-4-*L/#VIZCJ-M;P12K9LB
M[DF9A\RYZY]<C\*QMB'U1IS8=;W/"(?#VISL5BLIY&'4*N:G_P"$4UK&?[+N
M^/\ IF?\*]PO1X7T^^-H=-FN)@R^:+:)Y/*R"1N(Z< G'7 Z5J6^D>';JSBN
MH((&MY5!1PQ ;/X_I0X8E*[:!5,,W97/G%M"OP2/LLN?]W_ZU1G2+Y&(-M-_
MW[;_  KZ4?PUHF[:;./..@=@?YU$_AK1%5F:U4*HR3YK@ =^]*V([HJ^'[,^
M;_L%W&59H)1CGF)A_,5WWAF[DL;I+R+[T,H;'J.X_$<5W\^E^'O(NI(XALM2
MRS'S'^0@9/?T/:O.]-'E7-W#_=D('X$BN_!^TM)3L:T>1IJ![PMS'-8K=1?/
M&T?F+CN,9KA7UW6O[!FU3^T[3,\)DBMPBAX2) OR@@[AC.2>F:T?!&HL;5M.
MFX*9>$D]5/4?@>?Q]JV1X>TF/[1ML(1]H'[T8^\,YQ[#(' ]*G2#::.?2$FF
M>?77B#65E^ROJ;1.=0MX27@C$D<;JQ8G *8Z$=^.:NZ9JFI7_A_6B;_,UC-*
ML-['$G[U4&1QC;S[=C^-=9)H&D"'R?[,M#&6#E3"I!8< _J?SIJVEM!;FUBM
MX4M\%?*5 %P>HQTYJG4C;1#E4C;1'GKZ]K,-CHDKZA=2_;(9IYO)ABW@*H(
MR,8&"?7D^U%KK_B.YDTV(WQ!GLC.Q@AA8D^8P!._ S@ 8![=.M=?J:6FF:=]
MKBTF*<V4;F)$1%\M<'=@G[HP.<9^AK,D.C?;=.LWT33Q'+!$X>0[!&)&;Y0
MA'7)Y*Y)]ZTC.+7PEJ<6OA)+S7[NW\4VFF17Z"%5CAFS&I+R.#A^G 'RG ('
M-*-:URTT\SO<BY0SR1F1;4$QK'GYL C@GJ>V.^15NQNM)N;>7[1IXM[=O+NX
MV4EBXW%$; &0WRC@9X(]ZDG/A6XLE66-FBA+.HV3!ANRS'UQP<YX'?%1IM8C
M3L=%;W!N=+MYV9&:6-7+("%.1GC/./K69;R:J9'Q:6(3<=I-V^2/IY?]:T\*
MD,:*@C50 $Q]T8Z522[M[:(-/*J9YY-82:6K,;-NR'$:PWW3IZ?4N_\ A1Y6
MM'_E[TY?^W9S_P"SU6U'Q'8:68);N=(+9F(EDE.-G'''4Y/'%6[[6+*PL8+M
MW,R7#HEN(2&,S/\ ="\XY]<X]Z2:>Q7)*Z5MQ/(UO_H(:;_X!R?_ !RD,.M#
M_E]TYO\ MUD'_M2H]/\ $5A?BXWB2S>WB$\B7152L9&=Y()&,=>>.^*E/B'0
MO*@E_MG3O+N&*0M]J3$C X(4YY(R.!ZTQ2BXNS$"ZR.LFGO_ , =?ZFHYWU<
M1G%K8/\ ]O;K_P"TS5E=4TYXS(M_:E%3S&83*0% 5BQYZ;70Y]&![BLQO%6@
MR17CIJ]D4M5#2,)U(VD*0PYY!W 9'?CK029.IZYJ>A:)JVK&RMEN+*U:6)3*
M9$<],'A37SUXW^(FK^/'L3JD%G"MGO\ +6V1E!W8R3N8_P!T>E>^^,+>]U/P
MOJEEIUN;FXN;8I'&HY;..GX9KY?N=/N[6ZEMYH426-MKKYBG:>XSGK0-)O8Z
M'P9XSU+P3J37NFQ6TLDL1C9;A69<$@]B/[HKW[1O$]WXQ^'MMJNH)#;S/<NC
M?9LJH"YY&XDC\Z^9X;5V>(#RSG 8M(H _'.*^A/">DW^D_"Q;'4X/L;F[EV>
M81]QEX;.?>A-,+-;G4:#8P:IX?U"T\\^1<1*/-;YCM.3DY_K40\+^%O/6XM=
M:%O,NS:\,T&1MQCJISR <'@8P !Q2:$MJ/">JQW!,ENEKME\@\D!6R%)_K6&
MMEHD,Z6\AOI&B"*N9+=T/S*H&_9C'/KGKD#FFXR;]U&D8*5SHY/!GAZ[NX[A
M-092C1,HC,!(V($'SE"_0#G=D'E2M;6B:19^&-.:"VDDEBEE\PLRH#N*@?P*
MH_A'.,DY)ZUP[Z9X?5+=2VHR))#&Z>9%;G:'!8#!7V/(X]ZZC2+6VTSPK;+I
MRW5S#)+Y@5V3>"W)SR% ]A2M-;H)P45>YTHN5(^Z:7SQ_=_6LQ9KPJ"EF!Q_
MRTF4?RS33+JV?ELK+_@5XP_]IT&1K>>/0TAG']VLK?K7_/CIW_@<_P#\:H\S
M6/XK&P_"]<_^TJ -7[0.ZFJE]>Q_9I(MK;F4@<57$M_C,EG%_P!L[C/\U%9F
MH74H<+)I]P$)PSEHRH'OA\X_"@"*WU;3;9]D^H6D3=Q),JG]36FNMZ2WW=4L
MF_W;A#_6JNDP0PJ!!#'&HZ!$ K7EN!! \LC[8T7<Q/84 5?[7T_M=QM_N\_R
MI/[9L/\ GLQ^D3_X5H?-ZT[<_P#>/YT 9O\ ;-A_SV(^L;#^E']L::!\U[ O
M^\X7^=:)W]V/YTW+>M &5+KNCJ#G5K >WVE/\:\Y^*=]:W7ANV>WG@N%%ZF0
MD@8'Y7]*]8D9MIR:\K^+-NAT2U:.%/.-Z@!"@$_*_&:J'Q(J'Q'F6CW4L>I&
MYB$<,J,A7:N%4CVKJK1-4DMV>/5H1M.P13NH+ ]>&X(Z]?4CO7+6$+SZQ+%<
M.L+2RKO=L87<<YZX[^M;;:$GE!TO4.2?EPNX .J\@,<<$M_P$_6N^*36JN56
M;NK2M\KEW&M6D,C)>6K@*29 8I)!E@<[N6SN.0>H).,<UH>%_$=UI>L:SK=U
M''=2V.C32B- L0<*Z-CY5P"23SCO6<=!LHT7%Y!*VTMN)(!P>G7_ #BEM].F
MB'B6QLK=[B630Y42.$%VD+/&"5 R?4C\*5514'9&5.4FW>5_E8X_XA_$^Y\?
MQV$,FFI916;LX5)C)O) '/ Z8/YUG^!O&,_@C6UU*WM5N2T;1M&[[00<=P/4
M _A7.W6F:A9736]UIUW;S+]Z*:)E8?4$9J:*RN':%5MIW9OX50Y_E7GW15F?
M6_P]\9OXY\/RZF]BMFT=PT!C67>#A5.<X'][I[5UM>9?!'3K_2O"5]:W]C<V
MC?;F=%N(F1F!1.>0,CBO3:!!1110 4444 %%%% '$IK5E9:G:6MW*(I;Z1U@
MR/E9ACY<]B=W'K6GK.OZ=H*6YOKN" SS)&HED"\$X+<]@.IKRSXI6IDTS3+@
M$A4N)(S_ ," /_LM<9XMDU;4=*TK5;]Y)=T'DLQ<D*59@/IN S[D&@+'T5JF
MMV>E6L4[[IO./[I8BOSC;N)R2!C SG/IZU'%XFTI[);J:<VZF9H667&58#<<
ME<C&WYMP.,<YJAING:=KWA71I[/=9I B2VYM\ Q,!AEP001G((/I5N/PCIBV
ML,$OG3*D[SOO?'FLRE3NP!E=IQM&!@8.1G-.UO,S3DY>1,OB+1G=T74(<Q_>
MY/J!GW&2.1QS4-QXGT:"\^R2WJ*VTLSGA%QCJW3^(?CQUHE\(Z%*26L3\Q).
MV:1<#T&&X7I\HX&!Q6-=1^&KV62=K"[E5BP(C>01GH#\@8#!(!QCD@'KS4F\
M*<Y_"KFOI6I0SZK:M$^Z&[B?8?[V,$?H#5ZZT^\:9_LIMHH=JJH* D 9SQMZ
M=./Q[8KD+ZZATQ]'NK/?]GA8,@9F9BG&<ELDDC/)K5\3?$?1_#DL, W7UQ(1
MOCMV4F)2,Y8YXR.WIS6%U.4H/H4XN"3-A[?5-KG[5;*_R@%AG:.<C[OKC\L\
M9Q3;E;@:#,+L1[C(2 HW#;GCA17,0_%71Y;NS2:QF@AN75'N)&4+%D<%L]N5
M.>P.>V*['6-BZ7(5("D@Y#;1^8Z5I&"3NF0V]F8=GJNF:+IEY=ZI/%#:*H5M
MX;!S_" >3]!7S=K5[97>OZA<Z7I\[64EP[0K%$55$R<  <=,5[%XC\.S^)KR
MVMXKV%($4DQN6E4LW?J/2LQ_@?-;V_FS:_:11CDNT)4#\=U1-2;UV-:;C&.^
MIY[X5U/3+'7[.;6K"86PD^9)HMR$8/4'KU'8UWWCZ5+_ , +=6LR/ +B-R0?
MO#D?GDU:M_@O/%$MU#KT$S [EEV,P(]!STQQ537M(FT3P9X@MWNDD1DB91M(
M ;> ?SXH@I)[:#J.,E>^IS]EXPU.X^'VH:&99"]HJ.9226\@M@KGV)0#';-2
M_!JZ6+QJ1)/+&)8VC1$8!'.,@,._0X]\57\.NMEX3U&^ M7F;$92Y<!6C'5>
M?[Q]^U8NEI+I.N22Q$1W$3)+&RY^5ASWZX/?VKIIQYI<IQXB3ITW,]MN]$U6
MSUO5)H+![V&[<W%N\4JH5E.,++EAN0888Y&'/J:63P9?2Z/H-@ZV,AMY9I;@
MW-L)X4WJV!Y>Y<X+ #!X//2NJT#68=>T>WU"' \P 2)G[CCJO^>V*TAVIRD_
MA9-.G%/GB]_U//9/AD!/$\>J1_N0&2:6S#W#,L:HH>3>-R H#MP.I&>A%A?
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MDE,G@U]#U\\_"Z'ROB;;#8R 0R_*QR1\OT%?0U<5;XCGJ*SL%%%%9&84444
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M^3N17144 >>^+OA?!KUO;+IETFGM;D[46/"D''&5(QT]ZY-O@[XCZ#5;1L<
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MD%QIMRNHW*X5S(0K$8'/SL<].YS7LM%*UMA1J2CL>"#P?X]555K#.!C@1?\
MQRF)X)\<@L4LY$W') :,9_*2O?J*7O\ \S-?K$NWYGBO@SP7XOTKQ2NIWMJB
M*D;+YCR(2S-QG"D]O6O78([[:#-*H/< 5=HIJ_5W,9S<G=C%1P.7S^%. ]Z6
MBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4TQHW5%/U%.HH :$5>B@?04ZBB@ I"JL,, 1[BEHH
MJ2Z98S?ZRUB;ZK59O#FCL<MIT!_X#6I10!FIH&DQGY+" ?\  :MQV=M#_JX(
MU^BBIZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
